118 related articles for article (PubMed ID: 9326355)
1. BCL-2 oncoprotein (p26) in splenic lymphoma with villous lymphocytes: a comparative study with other chronic B-cell disorders.
Lima M; dos Anjos Teixeira M; Queirós ML; Ribeiro dos Santos AH; Justiça B
Am J Hematol; 1997 Oct; 56(2):122-5. PubMed ID: 9326355
[TBL] [Abstract][Full Text] [Related]
2. Splenic lymphoma with villous lymphocytes: case report and literature review.
Babadoko AA; Hassan A; Ahmed AJ; Isah HA; Suleiman AM
Niger J Med; 2007; 16(1):71-3. PubMed ID: 17563973
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
Del Giudice I; Matutes E; Morilla R; Morilla A; Owusu-Ankomah K; Rafiq F; A'Hern R; Delgado J; Bazerbashi MB; Catovsky D
Haematologica; 2004 Mar; 89(3):303-8. PubMed ID: 15020268
[TBL] [Abstract][Full Text] [Related]
4. Current approach to the biology and treatment of chronic lymphoid malignancies other than CLL.
Catovsky D
Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S63-6. PubMed ID: 9137958
[TBL] [Abstract][Full Text] [Related]
5. A rare case of B-lymphoproliferative disorder with villous lymphocytes harboring t(8;14)(q24;q32) translocation.
Shi X; Ba R; You H; Jiang Q; Huang J; Mao J; Han L; Zhang S; Zhuang Q; Yu X; Wang L; Wang Y; Li D; Zhu W; Zhang Y; Zhu Y; Xi X
Front Med; 2018 Jun; 12(3):324-329. PubMed ID: 29075958
[TBL] [Abstract][Full Text] [Related]
6. Splenic lymphoma with villous lymphocytes.
Gupta R; Naseem S; Sukumaran S; Kashyap R; Kaur S; Paul L
Indian J Pathol Microbiol; 2008; 51(1):113-5. PubMed ID: 18417879
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclins D-type in B-chronic lymphoproliferative disorders.
Sola B; Roué G; Duquesne F; Avet-Loiseau H; Macro M; Salaün V; Troussard X
Leukemia; 2000 Jul; 14(7):1318-9. PubMed ID: 10914560
[No Abstract] [Full Text] [Related]
8. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
9. Splenic lymphoma with circulating villous lymphocytes.
Imbing F; Kumar D; Kumar S; Yuoh G; Gardner F
J Clin Pathol; 1995 Jun; 48(6):584-7. PubMed ID: 7665709
[TBL] [Abstract][Full Text] [Related]
10. Splenic B-cell lymphoma with villous lymphocytes (SLVL). A lymphocytic lymphoma simulating hairy cell leukemia. A study of 8 cases.
Valensi F; Durand V; Bastenaire B; Flandrin G
Nouv Rev Fr Hematol (1978); 1990; 32(6):409-14. PubMed ID: 2101874
[TBL] [Abstract][Full Text] [Related]
11. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
[TBL] [Abstract][Full Text] [Related]
12. [Question of differential diagnosis in a case of chronic B-cell lymphopathy].
Moccia F; Casti P; Morra L
Clin Ter; 1993 May; 142(5):421-31. PubMed ID: 8339525
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation.
Menendez P; Vargas A; Bueno C; Barrena S; Almeida J; De Santiago M; López A; Roa S; San Miguel JF; Orfao A
Leukemia; 2004 Mar; 18(3):491-8. PubMed ID: 14724650
[TBL] [Abstract][Full Text] [Related]
14. The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH.
Gruszka-Westwood AM; Matutes E; Coignet LJ; Wotherspoon A; Catovsky D
Br J Haematol; 1999 Mar; 104(3):600-4. PubMed ID: 10086800
[TBL] [Abstract][Full Text] [Related]
15. The expression of PRAME in chronic lymphoproliferative disorders.
Proto-Siqueira R; Falcão RP; de Souza CA; Ismael SJ; Zago MA
Leuk Res; 2003 May; 27(5):393-6. PubMed ID: 12620290
[TBL] [Abstract][Full Text] [Related]
16. Levels of expression of CD19 and CD20 in chronic B cell leukaemias.
Ginaldi L; De Martinis M; Matutes E; Farahat N; Morilla R; Catovsky D
J Clin Pathol; 1998 May; 51(5):364-9. PubMed ID: 9708202
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of bcl-2 (p26) in CD8(+) lymphocytes of patients with T-cell lymphoproliferative disorders of large granular lymphocytes.
Lima M; Teixeira Mdos A; Dos Santos AH; Queirós ML; Justiça B
Hematol Oncol; 1997 May; 15(2):81-91. PubMed ID: 9375033
[TBL] [Abstract][Full Text] [Related]
18. Outline for writing an article for current treatment options in oncology: splenic lymphoma with villous lymphocytes.
Troussard X; Cornet E
Curr Treat Options Oncol; 2007 Apr; 8(2):97-108. PubMed ID: 17634839
[TBL] [Abstract][Full Text] [Related]
19. [Splenic lymphoma with circulating villous lymphocytes].
Colović M; Janković G; Colović R; Mijović A; Antunović P
Srp Arh Celok Lek; 1994; 122(3-4):103-4. PubMed ID: 17972822
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
Campàs C; Cosialls AM; Barragán M; Iglesias-Serret D; Santidrián AF; Coll-Mulet L; de Frias M; Domingo A; Pons G; Gil J
Exp Hematol; 2006 Dec; 34(12):1663-9. PubMed ID: 17157163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
